Cayuga Biotech
2 known investors
Cayuga Biotech develops first-in-class therapeutics to control life-threatening hemorrhage and treat bleeding disorders, targeting cases such as noncompressible hemorrhage and coagulation dysfunction from blood thinners. The company applies proprietary biomimetic science based on the body's natural clotting mechanisms.
BiotechHealthtechMedical Devices
Investors · 2
In the news
Frequently asked questions
- What does Cayuga Biotech do?
- Cayuga Biotech develops first-in-class therapeutics to control life-threatening hemorrhage and treat bleeding disorders, targeting cases such as noncompressible hemorrhage and coagulation dysfunction from blood thinners. The company applies proprietary biomimetic science based on the body's natural clotting mechanisms.
- Who are Cayuga Biotech's investors?
- Cayuga Biotech's investors include SOSV, TBD Angels.